|
Volumn 4, Issue 4, 2007, Pages 165-167
|
Prescription of fixed dose combination drugs for diarrhoea.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIPROTOZOAL AGENT;
CIPROFLOXACIN;
DRUG DERIVATIVE;
METRONIDAZOLE;
NORFLOXACIN;
SECNIDAZOLE;
TINIDAZOLE;
ARTICLE;
CLINICAL PRACTICE;
DIARRHEA;
DRUG COMBINATION;
DRUG COST;
DRUG INDUSTRY;
DRUG USE;
ECONOMICS;
ETHICS;
FINANCIAL MANAGEMENT;
HUMAN;
INDIA;
MEDICAL AUDIT;
PATIENT SELECTION;
PRESCRIPTION;
SOCIOECONOMICS;
STATISTICS;
ANTI-BACTERIAL AGENTS;
ANTIPROTOZOAL AGENTS;
CIPROFLOXACIN;
DIARRHEA;
DRUG COSTS;
DRUG INDUSTRY;
DRUG THERAPY, COMBINATION;
DRUG UTILIZATION REVIEW;
HUMANS;
INDIA;
MARKETING OF HEALTH SERVICES;
MEDICAL AUDIT;
METRONIDAZOLE;
NORFLOXACIN;
PATIENT SELECTION;
PHYSICIAN'S PRACTICE PATTERNS;
PRESCRIPTIONS, DRUG;
SOCIOECONOMIC FACTORS;
TINIDAZOLE;
MLCS;
MLOWN;
|
EID: 49249116367
PISSN: None
EISSN: None
Source Type: Journal
DOI: 10.20529/ijme.2007.065 Document Type: Article |
Times cited : (19)
|
References (0)
|